Stephens Inc’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-42,647
| Closed | -$1.22M | – | 1181 |
|
|
2019
Q3 | $1.22M | Sell |
42,647
-5,720
| -12% | -$164K | 0.03% | 507 |
|
|
2019
Q2 | $1.34M | Buy |
48,367
+1,997
| +4% | +$55.5K | 0.03% | 503 |
|
|
2019
Q1 | $1.54M | Buy |
46,370
+4,201
| +10% | +$139K | 0.04% | 465 |
|
|
2018
Q4 | $1.23M | Sell |
42,169
-3,389
| -7% | -$98.5K | 0.03% | 469 |
|
|
2018
Q3 | $2.1M | Buy |
+45,558
| New | +$2.1M | 0.05% | 393 |
|
|
2017
Q3 | – | Sell |
-307,413
| Closed | -$7.94M | – | 812 |
|
|
2017
Q2 | $7.94M | Sell |
307,413
-70,386
| -19% | -$1.82M | 0.27% | 70 |
|
|
2017
Q1 | $7.25M | Buy |
377,799
+67,303
| +22% | +$1.29M | 0.26% | 78 |
|
|
2016
Q4 | $5.18M | Buy |
310,496
+240,340
| +343% | +$4.01M | 0.21% | 106 |
|
|
2016
Q3 | $1.44M | Buy |
70,156
+68,806
| +5,097% | +$1.42M | 0.06% | 302 |
|
|
2016
Q2 | $41K | Sell |
1,350
-3,735
| -73% | -$113K | ﹤0.01% | 740 |
|
|
2016
Q1 | $190K | Sell |
5,085
-680
| -12% | -$25.4K | 0.01% | 659 |
|
|
2015
Q4 | $249K | Buy |
5,765
+2,020
| +54% | +$87.2K | 0.01% | 592 |
|
|
2015
Q3 | $140K | Buy |
3,745
+3,220
| +613% | +$120K | 0.01% | 679 |
|
|
2015
Q2 | $18K | Sell |
525
-10,035
| -95% | -$344K | ﹤0.01% | 784 |
|
|
2015
Q1 | $374K | Buy |
10,560
+9,130
| +638% | +$323K | 0.02% | 561 |
|
|
2014
Q4 | $49K | Buy |
1,430
+265
| +23% | +$9.08K | ﹤0.01% | 774 |
|
|
2014
Q3 | $45K | Sell |
1,165
-3,405
| -75% | -$132K | ﹤0.01% | 780 |
|
|
2014
Q2 | $178K | Buy |
4,570
+3,220
| +239% | +$125K | 0.01% | 760 |
|
|
2014
Q1 | $46K | Hold |
1,350
| – | – | ﹤0.01% | 762 |
|
|
2013
Q4 | $28K | Sell |
1,350
-200
| -13% | -$4.15K | ﹤0.01% | 836 |
|
|
2013
Q3 | $36K | Sell |
1,550
-3,200
| -67% | -$74.3K | ﹤0.01% | 780 |
|
|
2013
Q2 | $128K | Buy |
+4,750
| New | +$128K | 0.01% | 683 |
|